Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled study of Brenipatide in adults with irritable bowel syndrome with constipation
CTR20261998Phase 2Active
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of brenipatide in irritable bowel syndrome (IBS), sponsored by Eli Lilly and Company. Started Jul 2026; status: active.
02
Drugs
brenipatide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on CTR20261998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261998.